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The global burden of kidney disease and the sustainable development 
goals
Valerie A Luyckx,a Marcello Tonellib & John W Staniferc
Introduction
The 17 sustainable development goals (SDGs) were adopted by 
the United Nations, as successors to the millennium develop-
ment goals, with the broad goal of achieving healthy people 
living on a healthy planet.1 Although only SDG 3, that is, to 
ensure healthy lives and promote well-being for all at all ages, is 
specifically focused on health,1 achievement of all of the SDGs 
should have health benefits via impacts on the environment, 
governance and society.
The Global action plan for the prevention and control 
of noncommunicable diseases 2013–2020 (hereafter called 
the 2013 action plan) outlined an approach to reduce the 
combined mortality from four major categories of noncom-
municable disease, i.e. cancer, cardiovascular disease, chronic 
respiratory disease and diabetes, by 25% by 2025.2 Previously, 
these four categories had been prioritized in the 2008–2013 
action plan because, collectively, they were believed to ac-
count for about 60% of global deaths and it was anticipated 
that a large proportion of these deaths could be prevented 
through elimination of shared risk factors, e.g. alcohol and 
tobacco use, poor diets and inadequate exercise.3 Although 
laudable, the 2013 action plan has been criticized for failing 
to acknowledge the broader drivers of the noncommuni-
cable disease epidemics, other important noncommunicable 
diseases and the so-called causes of the causes of noncom-
municable diseases and failing to place sufficient emphasis 
on the need for coordinated multisectoral action.4 We argue 
that kidney disease represents one of the important noncom-
municable diseases missing from the 2013 action plan and 
that, given the many social and structural factors that directly 
affect risks and outcomes of kidney disease, multisectoral 
action to achieve the SDGs will help prevent and control 
such disease (Table 1).1
Global burden
Although often considered a comorbidity of diabetes or hy-
pertension, kidney disease has numerous complex causes.5 
Importantly, such disease has an indirect impact on global 
morbidity and mortality by increasing the risks associated 
with at least five other major killers: cardiovascular diseases, 
diabetes, hypertension, infection with human immunode-
ficiency virus (HIV) and malaria. For example, the Global 
Burden of Disease (GBD) 2015 study estimated that 1.2 million 
deaths, 19 million disability-adjusted life-years (DALYs) and 
18 million years of life lost from cardiovascular diseases were 
directly attributable to reduced glomerular filtration rates.6,7
The GBD 2015 study also estimated that, in 2015, 1.2 
million people died from kidney failure, an increase of 32% 
since 2005.7 In 2010, an estimated 2.3–7.1 million people 
with end-stage kidney disease died without access to chronic 
dialysis.8 Additionally, each year, around 1.7 million people are 
thought to die from acute kidney injury.9 Overall, therefore, 
an estimated 5–10 million people die annually from kidney 
disease. Given the limited epidemiological data, the common 
lack of awareness and the frequently poor access to labora-
tory services, such numbers probably underestimate the true 
burden posed by kidney disease. It is therefore possible that, 
each year, at least as many deaths are attributable to kidney 
disease as to cancer, diabetes or respiratory diseases, three of 
the four main categories targeted by the 2013 action plan.2,10,11 
In addition, the estimated number of DALYS attributable to 
kidney disease globally increased from 19 million in 1990 to 33 
million in 2013.12 In 2016, the DALYs associated with chronic 
kidney disease, along with those associated with cardiovas-
cular disease, cancers, diabetes and neurological disorders, 
were found to have increased significantly between 1990 and 
2015.6 A report from the GBD 2016 study highlighted the 
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Table 1. The 17 sustainable development goals and their relevance to kidney health, 2015
Goal Description Relevance to kidney health Relevant 
SDG 3 targets
1 End poverty in all its forms 
everywhere
• Improvements in access to nutrition, personal safety and health care should 
enhance the prevention, detection and management of kidney disease
• Should reduce the incidence of catastrophic health expenditure resulting from 
treatment for kidney disease
3.8
2 End hunger, achieve food security 
and improved nutrition and 
promote sustainable agriculture
• Improvements in maternal nutrition and reductions in the frequencies of low 
birth weight and preterm birth should reduce the risk of CKD
• Reductions in the incidence of obesity should cut the risk of CKD, diabetes and 
hypertension
3.1, 3.2
3 Ensure healthy lives and promote 
well-being for all at all ages
• Should improve screening for, and the prevention, diagnosis and treatment of, 
kidney disease
• Public health programmes to promote community education, healthy lifestyles 
and vaccinations could also reduce the risk of AKI and CKD
All
4 Ensure inclusive and equitable 
quality education for all and 
promote life-long learning
• Should improve awareness and kidney-health-related knowledge
• May reduce use of nephrotoxic remedies and preparations
3.4, 3.5
5 Achieve gender equality and 
empower women and girls
• Reductions in the numbers of teenage pregnancies and increases in pregnancy 
spacing may reduce the incidence of the low birth weight, prematurity and 
pregnancy-related complications that are all risk factors for CKD
• There should also be improvements in overall family health
3.1, 3.7
6 Ensure access to water and 
sanitation for all
• There should be reductions in the incidence of the waterborne diseases and 
diarrhoeal illnesses that are major causes of AKI and in the incidence of the 
schistosomiasis that can cause CKD
• There should also be reductions in water pollution that can cause CKD
3.9
7 Ensure access to affordable, 
reliable, sustainable and modern 
energy for all
• Should broaden opportunities to use mobile health in prevention and 
treatment and in community and health worker education
• Improvements in access to electronic information sharing and data collection 
could lead to improvements in the epidemiology, monitoring and surveillance 
of kidney disease
3.9
8 Promote inclusive and sustainable 
economic growth, employment 
and decent work for all
• Improvements in personal access to health care, dignity and wealth could lead 
to improvements in the prevention and early treatment of kidney disease
• Improvements in the retention of health-care workers could reduce the so-
called brain drain
• Task shifting in health care could be facilitated
3.b, 3.c
9 Build resilient infrastructure, 
promote sustainable 
industrialization and foster 
innovation
• Could support innovations to improve the affordability and sustainability of 
access to diagnosis, facilitate early treatment and secondary prevention and 
foster cheaper and more efficient means to prevent, diagnose and treat both 
AKI and CKD
• Could also facilitate investigation of the potential benefits of, or risks posed by, 
traditional remedies for kidney disease
3.b
10 Reduce inequality within and 
among countries
• Could improve equity in the prevention, diagnosis and care of all forms of 
kidney disease
• Could improve access to expensive therapies, e.g. dialysis, hepatitis C therapy 
and transplantation
• Could improve geographical access to all forms of kidney care
3.1, 3.2, 3.7, 
3.8, 3.b, 3.d
11 Make cities inclusive, safe, resilient 
and sustainable
• Improved warning and protection from disasters could reduce crush-injury-
related AKI
• Levels of preparedness in mass disasters, including for patients with AKI, CKD or 
ESKD, should improve
• Urban planning to eliminate food deserts and increase physical activity could 
help reduce diabetes and obesity-related kidney disease
• Reductions in exposure to alcohol, drugs and tobacco could also reduce the 
risk of kidney disease
3.5, 3.6, 3.d
12 Ensure sustainable consumption 
and production patterns
• Promotion of the environmentally friendly and sustainable local production of 
dialysis supplies could reduce dialysis costs, create jobs and support the local 
economy
• Any reductions in the need for dialysis should reduce the carbon footprint from 
dialysis
• There may also be adverse effects on kidney health as increasing access to 
cars and unhealthy processed foods could lead to an increasing prevalence of 
obesity and access to cigarettes may also increase
3.4, 3.5, 3.9
(continues. . .)
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important omission of focus on chronic 
kidney disease and suggested that “the 
SDG agenda offers at best a minimal 
platform for drawing attention to the 
health care and monitoring needs of 
[chronic kidney disease].”13
Kidney disease is associated with 
a tremendous economic burden. High-
income countries typically spend more 
than 2–3% of their annual health-care 
budget on the treatment of end-stage 
kidney disease, even though those re-
ceiving such treatment represent under 
0.03% of the total population.14 In 2010, 
2.62 million people received dialysis 
worldwide and the need for dialysis was 
projected to double by 2030.8 Globally, 
the total cost of the treatment of the 
milder forms of chronic kidney disease 
appears to be much greater than the total 
cost of treating end-stage kidney disease. 
In 2015, in the United States of America, 
for example, Medicare expenditures on 
chronic and end-stage kidney disease 
were more than 64 billion and 34 bil-
lion United States dollars, respectively.15 
Much of the expenditure, morbidity and 
mortality previously attributed to diabe-
tes and hypertension are attributable to 
kidney disease and its complications.12,16
Worldwide, important risk fac-
tors for kidney disease include diar-
rhoeal diseases, HIV infection, low birth 
weight, malaria and preterm birth, all of 
which are also leading global causes of 
DALYs.12 Risks of kidney disease span 
the life-course and environmental, in-
fection and lifestyle etiologies.17 If risk 
factors are identified early, acute kidney 
injury and chronic kidney disease can 
be prevented and, if kidney disease is 
diagnosed early, worsening of kidney 
function can be slowed or averted by 
inexpensive interventions, several of 
which are on the World Health Orga-
nization’s (WHO’s) so-called best buys 
list for noncommunicable disease man-
agement.18 Such interventions include 
counselling for cardiovascular disease, 
diabetes and hypertension, drug therapy, 
tobacco control, promotion of physical 
activity and the reduction of salt intake 
through legislation and food labelling. 
The timely identification and manage-
ment of acute kidney injury and chronic 
kidney disease represent the most ef-
fective strategy to address the growing 
global burden sustainably.4,5 By advocat-
ing for a multisectoral approach, as a 
means to achieving the SDGs, it should 
be possible to reduce the incidence of 
kidney disease globally.19 We discuss 
the kidney-health-related opportunities 
offered by attempts to achieve each SDG 
(Table 1).
SDGs and kidney health
SDGs 1, 3.8, 3.b and 10
In high-income countries, lower so-
cioeconomic status is associated with 
greater risk of end-stage kidney disease 
because of behavioural and metabolic 
risk factors and reduced access to care.20 
In low- and middle-income countries, 
the burden posed by such poverty-
related kidney disease is even greater, 
because of associated infections, hazard-
ous work, poor education and poor ma-
ternal health. In all countries, poverty is 
associated with lack of social protection 
and transportation, poor housing and 
unemployment.20 Lack of transporta-
tion restricts access to care even when 
treatment costs are not a major barrier.20 
Poverty and lower socioeconomic status 
have been specifically identified as inde-
pendent risks for both incident chronic 
kidney disease and the more rapid pro-
gression of such disease.20 In low-income 
countries where treatment costs have to 
be paid directly by patients, a month’s 
supply of essential medications for the 
treatment of chronic kidney disease can 
cost up to 18 days’ wages21 and the corre-
sponding out-of-pocket costs of dialysis, 
for acute kidney injury or end-stage 
kidney disease, are much higher.22,23 In 
South Africa, where limited access to 
dialysis is government-funded, patients 
who are otherwise eligible for dialysis 
are frequently declined access because 
of their socioeconomic circumstances.24 
For those who do access dialysis, the 
financial burden is exacerbated because 
they cannot be employed while receiv-
ing dialysis or travelling to and from 
the provider.
Goal Description Relevance to kidney health Relevant 
SDG 3 targets
13 Take urgent action to combat 
climate change and its impacts
• Global warming may have contributed to an epidemic of Central American 
nephropathy and to CKD of unknown origin that appears related to 
dehydration and toxin exposure
• The adverse effects of climate change on the transmission of pathogens 
causing infectious disease and poverty may increase the risk of CKD
3.2, 3.3, 3.d
14 Conserve and sustainably use the 
oceans, seas and marine resources
• Exposure to marine pollution may increase the risk of CKD 3.9, 3.d
15 Sustainably manage forests, 
combat desertification and halt 
and reverse land degradation and 
halt biodiversity loss
• Any reduction in the leaching of toxins from industrial waste into ground water 
could reduce the risk of the CKD associated with such pollution
3.9, 3.d
16 Promote just, peaceful and 
inclusive societies
• Any reduction in armed conflict could reduce the risk of AKI associated with 
crush injuries and major trauma and improve food security
• The incidence of low birth weight, which is a risk factor for CKD, tends to 
increase during wars
• Among prisoners and other marginalized populations, improvements in equity 
and justice could facilitate the prevention, diagnosis and treatment of kidney 
disease
3.d
17 Revitalize the global partnership 
for sustainable development
• Improved global partnerships for health-care financing and regulation and 
health-related development and research could accelerate our understanding 
of kidney disease, reduce inequities in kidney care and reduce so-called 
transplant tourism
3.d
AKI: acute kidney injury; CKD: chronic kidney disease; ESKD: end-stage kidney disease; SDG: sustainable development goal.
(. . .continued)
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Promotion of universal health 
coverage should reduce the financial 
hardship of patients with kidney disease 
and improve access to kidney care.25 The 
goal of eradicating poverty spans all 
of the other SDGs and is fundamental 
to improving kidney health. In turn, 
achievement of each SDG promises to 
promote equity and reduce poverty.20
SDG 2
Many low-income countries have 
problems with undernutrition and 
overnutrition, both are risk factors for 
kidney disease. Malnutrition predis-
poses young children to infections, e.g. 
diarrhoeal diseases and pneumonia, 
that are important risk factors for acute 
kidney injury.22 Among girls and female 
adolescents, undernutrition leads to 
underweight mothers and low-birth-
weight offspring.26 Low birth weights, 
preterm births and pregnancies affected 
by diabetes and pre-eclampsia, which, 
combined, may represent up to 20% 
of pregnancies worldwide, are all as-
sociated with increased lifetime risk of 
chronic kidney disease in both mothers 
and children.26 Obesity increases the 
lifetime risk of end-stage kidney dis-
ease17 and maternal obesity is associated 
with adverse outcomes in pregnancy,26 
including the gestational diabetes and 
preterm births that are associated with 
increased risk of chronic kidney disease.
Adequate nutrition is a key tool 
for reducing the burden of chronic 
kidney disease. Groups with very low 
incomes often live in areas where ac-
cess to healthful foods is very limited 
or non-existent.20 Some population-level 
strategies, e.g. public education about 
healthful food choices, regulation of the 
fat, salt and/or sugar contents of food 
and the regulation of programmes for 
the provision of public and/or school 
meals, can all improve kidney health.27 
Reduction in dietary salt is proposed as 
a cost-saving best buy with great poten-
tial to avert deaths from kidney disease. 
Similarly, a tax on high-sugar beverages, 
as introduced in Mexico, where chronic 
kidney disease is the second leading 
cause of death, can lead to sustained 
decreases in the purchase of taxed drinks 
and may reduce diabetes-related kidney 
disease over time.28
SDG 3
SDG 3 has many l inks to better 
kidney health (Table 2 available at: 
http://www.who.int/bul let in/vol-
umes/96/6/17-206441) including opti-
mization of fetal development, preven-
tion of infections, reduction of the mor-
tality and morbidity of cardiovascular 
disease and mitigation of environmental 
exposures. The Global Kidney Health 
Atlas has provided an overview of the 
main gaps in kidney care globally: an 
absence of relevant policies, shortages 
of essential medications, reliable epi-
demiological data, relevant workforce 
capacity, infrastructure and research 
capacity and a persistent reliance on out-
of-pocket payments.29 The Atlas empha-
sizes the need for a health-system-wide 
approach to kidney care and provides a 
baseline against which to measure prog-
ress. Work towards reducing the global 
burden of kidney disease will contribute 
to achieving SDG 3 (Table 2).
SDGs 4 and 5
Because they are, in general, responsible 
for most child care and housework, 
women in low- and middle-income 
countries may face greater challenges if 
they have chronic kidney disease – and 
other noncommunicable diseases, than 
men with similar health problems.30 
Heavy demands on their time may ex-
plain why, even though chronic kidney 
disease is more common among women 
than men, fewer women than men re-
ceive dialysis.30 Child marriage and lack 
of access to family planning contribute 
to poor maternal health and increased 
risk of obstetrical complications, includ-
ing acute kidney injury.31 Among urban 
adults in the United States, both gender 
and race appeared to affect glomerular 
filtration rates.32 Achievement of equity 
for women worldwide should reduce the 
burden of kidney disease.
SDG 6
Globally, almost 800 million people 
lack access to safe water and 2.5 billion 
lack access to optimal sanitation.33 In 
low- and middle-income countries, 
waterborne and pestilent diseases as-
sociated with poor hygiene and sanita-
tion are major causes of acute kidney 
injury and chronic kidney disease.34 
Enteric diarrhoeal deaths, associated 
with lack of safe water, cause over 1 
million deaths annually.13 Most of these 
deaths occur in children younger than 
five years and many can be attributed 
to dehydration-related acute kidney 
injury.13 Non-enteric diseases caused by 
waterborne pathogens, e.g. leptospirosis 
and schistosomiasis, are also major 
causes of kidney disease in low- and 
middle-income countries.34
Local availability of clean water 
would be expected to reduce the risk of 
diarrhoea-related acute kidney injury.35 
Beyond infection-related kidney com-
plications from contaminated water and 
poor sanitation, additional challenges 
exist. Water containing organic perfluo-
roalkyl acids and heavy metals has been 
associated with chronic kidney disease 
in several settings and pesticide-con-
taminated well water may contribute to 
the risk of some chronic kidney disease 
observed in Sri Lanka.36 Dehydration, in 
conjunction with heat stress, may have 
contributed to the epidemic of chronic 
kidney disease observed among young, 
economically productive male labour-
ers in Central America and South-East 
Asia.36 The global burden of kidney dis-
ease should be reduced by ensuring the 
availability of clean water and adequate 
sanitation.
SDGs 7 and 12–15
Climate change, degradation of bio-
diversity, forest and land, and loss of 
marine resources, all likely increase 
the risk of kidney disease through 
multiple mechanisms, e.g. increases in 
food insecurity, the incidences of heat-
related illness and infectious diseases 
and pollution.37 Deforestation and land 
degradation can bring humans into 
greater contact with vector-borne and 
waterborne pathogens, such as enteric 
bacteria and other pathogens that can 
directly cause kidney disease, e.g. those 
causing dengue fever, leishmaniasis, 
leptospirosis, malaria, schistosomiasis, 
trypanosomiasis and yellow fever.38
Reducing the global burden of 
kidney disease in turn will also be criti-
cal for mitigating some of the environ-
mental impacts of dialysis. Each year, 
for example, the haemodialysis given 
to more than 2 million people requires 
160 billion litres of water and generates 
over 900 000 tonnes of, predominantly 
plastic waste.39 Clean, local production 
of dialysis supplies, the reprocessing 
of dialysis filters, the reuse of dialysis 
water, solar-powered dialysis and water-
less dialysis are all promising strategies 
that could creduce the environmental 
footprint of dialysis as well at its costs.39
SDGs 8, 10 and 17
Within low- and middle-income coun-
tries, access to dialysis is highly inequi-
table.8 Despite its relative cost–effective-
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ness, access to transplantation is even 
more inequitable because of cultural, 
financial and legislative barriers and 
infrastructural limitations.40 In the face 
of extreme social inequalities and a 
demand for transplants that markedly 
exceeds the supply, the trafficking of kid-
neys and other human organs remains a 
major concern.40
Disparities in the burden of kidney 
disease, which are particularly complex, 
arise from biological, environmental, 
genetic, lifestyle and sociocultural 
factors20 and need to be addressed via 
multilevel, systematic interventions.34 
An example of the complexities involved 
has been described in the United States. 
There, in general, compared with other 
patients with similar disease, patients 
with chronic kidney disease from eth-
nic and racial minorities have delayed 
referral for care, lower incomes, report 
poorer physician–patient relationships 
and have less access to health care in 
general.20 The pervasive disparities 
in kidney disease will have to be ad-
dressed before SDGs 8, 10 and 17 can 
be achieved.
SDGs 3.6, 3.d, 9 and 11
Rapidly occurring urbanization has 
contributed to the rise of kidney disease 
and other noncommunicable diseases 
in low- and middle-income countries.41 
In addition to the commonly associated 
lifestyle changes, e.g. a switch to high-
calorie, sodium-rich diets and decreased 
physical activity, rapid urbanization has 
led to crowded cities with environmen-
tal pollution, a limited infrastructure 
and poor levels of sanitation and waste 
disposal.42 Such urbanization also means 
that more and more people are living in 
settings where a growing prevalence of 
noncommunicable diseases, e.g. diabe-
tes, hypertension and obesity, is juxta-
posed with environmental toxins and 
numerous infectious diseases.42 These 
changes portend a synergistic growth 
in the global burden of kidney disease. 
There may already be evidence of such 
growth in the ever-higher ranking of 
chronic kidney disease among lead-
ing cause of deaths, across all country 
income categories, between 1990 and 
2016.13
By building resilient infrastructure 
while promoting sustainable industrial-
ization, it should be possible to enhance 
health-care access while simultaneously 
reducing the risk of kidney disease. In 
low- and middle-income countries, 
urban planning, to improve hygiene 
and sanitation and reduce population 
densities and the transmission of the 
pathogens causing enteric infections, 
schistosomiasis and tuberculosis, should 
reduce the incidence of acute kidney 
injury and chronic kidney disease.17 
At the same time, by promoting the 
development of parks, paths and effi-
cient transport systems, urban planning 
could increase general levels of physical 
activity and so help reduce the risk of 
obesity-related kidney disease.42
The effective prevention of chronic 
kidney disease will require engagement 
with the corporate sector, whose inter-
ests may be in conflict with those of pub-
lic health.43 Novel strategies are required 
to create incentives for the corporate 
sector to promote public health.44 Even 
under optimal circumstances, kidney 
disease cannot always be prevented 
and strategies to reduce the economic, 
physical and social burdens of end-stage 
kidney disease are needed. Innovative 
mechanisms to reduce dialysis costs and 
make dialysis less dependent on electric-
ity and water could multiply opportuni-
ties for access to dialysis, especially in 
low- and middle-income countries.39 
Innovation is also required to improve 
access to transplantation. Although opt-
out or presumed-consent strategies have 
been proposed as a way of increasing the 
supply of organs from deceased donors, 
they remain contentious.
Acute kidney injury after a road-
traffic collision may result from rhabdo-
myolysis and multi-organ failure as well 
as blunt or penetrating kidney injury.45 
Natural disasters are associated with 
increased rates of crush-injury-induced 
acute kidney injury and frequently lead 
to life-threatening interruptions of treat-
ment among those with end-stage kid-
ney disease.46 Similarly, forced migrants 
with chronic or end-stage kidney disease 
can face dangerous interruptions in their 
treatment or receive inadequate care,47 
even in a high-income country such as 
the United States.48 Continued action on 
reducing the burden of road-traffic inju-
ries and supporting efforts to integrate 
noncommunicable disease management 
into humanitarian relief efforts should 
help to reduce the burden of chronic 
and end-stage kidney disease.46
SDG 16
Exposure to armed conflict can result 
in acute kidney injury caused by crush 
injury and rhabdomyolysis and the 
severity of injuries sustained in combat 
strongly correlates with the subsequent 
risk of chronic kidney disease.49 Kid-
ney disease is common in incarcerated 
populations and, in terms of their kid-
ney health, prisoners may face a triple 
burden: of excess risk of kidney disease 
and its risk factors, of barriers to preven-
tive care for established chronic kidney 
disease and of the suboptimal manage-
ment of end-stage kidney disease.50 As 
an important step towards improving 
global health, much work is required 
globally to reduce conflict and dispari-
ties and enhance peace.
Policy perspective
The net health burden of kidney disease 
is substantial, growing and driven by 
complex interactions, between commu-
nicable and noncommunicable diseases, 
that are shaped by upstream environ-
mental and socioeconomic disparities. 
Although kidney disease, whether acute, 
chronic or end-stage, can be extremely 
costly, it is also potentially preventable 
and adverse outcomes can often be 
delayed or prevented by inexpensive 
interventions. Kidney disease is highly 
prevalent, spans the life course and has 
substantial financial implications. Our 
response to such disease requires a sys-
tematic policy approach, to strengthen 
all relevant aspects of the health sys-
tem and to facilitate integration of the 
promotion of kidney health within a 
comprehensive horizontal programme 
for the prevention and treatment of 
noncommunicable diseases (Table 2).
Within each country, the local bur-
den and prevalence of kidney disease 
and its risk factors and the local capac-
ity to identify and manage such disease 
must be determined, as a prerequisite 
for fair priority setting and appropri-
ate policy development. Diagnosis of 
kidney disease is often hampered by a 
lack of awareness among health-care 
workers and at-risk communities and 
by inadequate and often erratic access 
to laboratory testing. Broad policies are 
increasingly being adopted globally to 
curb dietary intakes of fat, salt and sugar. 
Such policies all promise to reduce the 
burden of chronic kidney disease. The 
burden of acute kidney injury could be 
reduced through the ongoing commit-
ment to reduce the transmission of the 
pathogens causing infectious diseases.
We need universal health coverage 
to tackle kidney disease successfully 
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and ensure effective screening, preven-
tion and early treatment. Effective and 
transparent policies to govern access 
to care for end-stage kidney disease 
should only be developed after there has 
been a thorough attempt to determine 
the local health priorities, especially in 
resource-poor settings. Engagement 
with all relevant stakeholders and in-
novative financing strategies will be 
required to maximize equitable access 
to care. The bidirectional and synergistic 
interplay between kidney disease and 
all of the SGDs must be acknowledged 
in the development of a multisectoral 
approach. Policies that foster domes-
tic and international collaboration, 
improve occupational and road safety, 
limit organ trafficking, promote access 
to education and gender equality, reduce 
unemployment and tackle the predicted 
adverse effects of climate change may 
all reduce kidney disease and/or the 
disparities in the care for such disease. 
However, as noted by the United Na-
tions Secretary-General in December 
2017, in the control and prevention 
of noncommunicable diseases, “politi-
cal commitments have not often been 
translated into concrete action.”51 On 
its own, policy-making is insufficient. 
Monitoring the impact of policies on 
kidney disease and the risk factors for 
such disease needs to be integrated into 
existing surveillance activities. Health 
workers and communities must be 
empowered to advocate for, and hold 
policy-makers accountable for, kidney 
health, as an important step towards 
achievement of the SDGs. ■
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صخلم
ةمادتسلما ةيمنتلا فادهأو لىكلا ضرلم يلماعلا ءبعلا
 لاو .لاهملإل ةضرع رثكلأا نمزلما ضرلما هنأب لىكلا ضرم فصُو
 ضرلم  يلماعلا  ءبعلا  مجلح  ةقوثوم  تاريدقتب  جورلخا  لىإ  ليبس
 حئاشرلا  لىإ  ةدنتسلما  تاساردلا  نم  ديزلما  ءارجإ  نود  نم  لىكلا
 فيطلا  ءاحنأ  فلتمخ  في  عقت  ةددمح  رطامخ  كانه  نأ  لاإ  ،ةيناكسلا
 ةيذغتلا ءوس نمو ،ءارثلا لىإ رقفلا ينب ام ،يداصتقلاا يعماتجلاا
 ،ةيعانصلا  دعب  ام  لىإ  ةيعارزلا  تائيبلا  فيو  ،ةدئازلا  ةنمِسلا  لىإ
 كانهو  .يننسلما  ىتح  اًثيدح  نيدولولما  نم  اًءدب  ةايلحا  رادم  لىعو
 ةباصإ  لىإ  يدؤت  يتلا  ةيراسلا  يرغو  ةيراسلا  ضارملأا  نم  ددع
 لىكلا  ضرمب ينباصلما نم ديدعلل ىنستي  لاو ،تافعاضمب لىكلا
 اتهاعبتو لىكلا ضارمأ تاببسلم نأ ماك .ةياعرلا لىع لوصلحا لبس
 عيجم  في  ةيمومعلا  ةحصلا  ةسايس  قتاع  لىع  عقت  تاعبت  اتهاقفنو
 لصلأا  لماوعب  لىكلا  ضرمب  ةباصلإا  رطامخ  رثأتت  ماك  .نادلبلا
 يدؤي  دقو  .ةايلحا  طمنو  عقولماو  يعماتجلاا  عونلاو  يقرعلا
 لاقتنلااو  ،ةرجلها  لماوعو  ،ةيحصلاو  ةيداصتقلاا  قراوفلا  ديازت
 ،ةيئيبلا  تاديدهتلاو  ،ةنملآا  يرغ  لمعلا  فورظو  ،فيارغوميدلا
 ةيعاسلا  تلاواحلما  ضيوقت  لىإ  ثولتلاو  ،ةيعيبطلا  ثراوكلاو
 .لىكلا  ضرم  نع  ةتجانلا  تايفولاو  ةباصلإا  بسن  نم  دلحا  لىإ
 يلماعلا  ءبعلا  عم  لماعتلل  تاعاطقلا  ددعتم  جنه  عابتا  مزليو
 جنه عابتا ةيهمأ لىع ةمادتسلما ةيمنتلا فادهأ دكؤتو .لىكلا ضرلم
 هيجوت  لىع  لمعن  نحنو  .ةحصلا  عم  يطاعتلل  تاعاطقلا  ددعتم
 لىع ةرداقلا ةمادتسلما ةيمنتلا  فادهأ عيجم قيقتح وحن تاءارجلإا
 في هجلاعو هنم ةياقولاو هسايقو لىكلا ضرم مهف تايوتسم ينستح
 لبس نم ززعت نأ تاءارجلإا هذله نكمي ماك .ةيرمعلا تائفلا عيجم
 ضرلما نع جتانلا ءبعلا مجح نم دتحو ،جلاعلا لامج في ريوطتلا
.ةلبقلما لايجلأا طاسوأ في
摘要
全球肾病负担和可持续发展目标
肾病被视为全球最被忽视的慢性疾病。全球肾病负担
的可靠预估需要更多基于人群的研究，但是特定风险
的发生横跨社会各经济范围，从贫困到富裕，从营养
不良到肥胖，从农耕时代到后工业时代，生命周期从
新生儿到老年人。肾脏并发症导致一系列可传染和不
可传染的疾病，许多患有肾病的人缺乏治疗途径。肾
病的成因、结果和成本对所有国家的公众健康政策都
有影响。肾病的风险也受种族、性别、地点和生活方
式的影响。日益扩大的经济健康差距、移民、人口转型、
不安全的工作条件和环境威胁、自然灾害与污染可能
会阻碍试图降低肾病发病率和死亡率的努力。解决全
球肾病负担需要多部门合作。可持续发展目标强调多
部门合作解决健康问题的重要性。我们列出达成可持
续发展目标所采取的措施，这些措施有提升各年龄群
体对肾病理解、测量、预防和治愈的潜力。这些措施
也可以促进治疗创新，减轻子孙后代的肾病负担。
Résumé
Charge mondiale de la maladie rénale et objectifs de développement durable
La maladie rénale est décrite comme la maladie chronique la plus 
négligée. Si d’autres études en population sont nécessaires pour 
établir des estimations fiables de la charge mondiale de la maladie 
rénale, les risques spécifiques sont présents dans l’ensemble du spectre 
socioéconomique, à la fois en situation de pauvreté et de richesse, 
de malnutrition et d’obésité, dans des environnements agricoles et 
postindustriels, et à tous les âges, aussi bien chez les nouveau-nés 
que chez les personnes âgées. Diverses maladies transmissibles et non 
transmissibles entraînent des complications rénales et de nombreuses 
personnes atteintes de maladie rénale n’ont pas accès aux soins. Les 
causes, les conséquences et les coûts de la maladie rénale ont une 
incidence sur la politique de santé publique dans tous les pays. Le risque 
de développer une maladie rénale est également influencé par l’origine 
ethnique, le sexe, le lieu et le mode de vie. L’accroissement des disparités 
économiques et sanitaires, les migrations, la transition démographique, 
les conditions de travail dangereuses, les menaces environnementales, 
les catastrophes naturelles et la pollution sont susceptibles de faire 
échouer les tentatives de réduction de la morbidité et de la mortalité 
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liées à la maladie rénale. Une approche multisectorielle est nécessaire 
pour faire face à la charge mondiale de la maladie rénale. Les objectifs 
de développement durable (ODD) soulignent l’importance d’une 
approche multisectorielle en matière de santé. Nous établissons une 
cartographie des actions à entreprendre pour atteindre tous les ODD qui 
sont susceptibles d’améliorer la connaissance, la mesure, la prévention 
et le traitement de la maladie rénale dans toutes les tranches d’âge. Ces 
actions peuvent également favoriser les innovations thérapeutiques et 
réduire la charge de cette affection pour les générations futures.
Резюме
Глобальное бремя хронической болезни почек и цели в области устойчивого развития
Хроническая болезнь почек известна как одно из тех хронических 
заболеваний, которым уделяется меньше всего внимания. 
Надежные оценки глобального бремени хронической 
болезни почек требуют проведения исследований, более 
ориентированных на популяционный уровень, но определенные 
риски возникают во всем социально-экономическом спектре: 
от нищеты до богатства, от недоедания до ожирения, от 
аграрного до постиндустриального сегментов общества, а 
также в течение всей жизни от новорожденных до взрослых 
людей. Ряд инфекционных и неинфекционных заболеваний 
приводит к осложнениям, затрагивающим почки, а многие люди 
с хронической болезнью почек не имеют возможности получить 
медицинскую помощь. Причины, последствия и расходы, 
связанные с заболеваниями почек, имеют значение для политики 
общественного здравоохранения во всех странах. Риск развития 
хронической болезни почек также зависит от этнической 
принадлежности, пола, территории проживания и образа жизни.  
Рост диспропорций в области экономики и здравоохранения, 
миграция населения, демографические изменения, небезопасные 
условия труда и экологические угрозы, стихийные бедствия 
и природное загрязнение могут помешать попыткам снизить 
заболеваемость хронической болезнью почек и связанную с 
ней смертность. Для решения проблемы глобального бремени 
хронической болезни почек необходим многосекторальный 
подход. Цели в области устойчивого развития подчеркивают 
важность многосекторального подхода к здравоохранению. 
Авторы составили план действий по достижению всех целей 
в области устойчивого развития, которые могут улучшить 
понимание аспектов хронической болезни почек во всех 
возрастных группах, а также исследование, профилактику и 
лечение этой болезни. Эти действия могут также способствовать 
инновациям в области лечения и уменьшить бремя этого 
заболевания для будущих поколений.
Resumen
La carga global de la insuficiencia renal y los objetivos de desarrollo sostenible
La insuficiencia renal se ha descrito como la enfermedad crónica más 
olvidada. Serían necesarios más estudios basados en la población para 
obtener estimaciones fiables de la carga mundial de la insuficiencia renal, 
pero existen riesgos específicos en todo el espectro socioeconómico 
desde la pobreza hasta la prosperidad, desde la desnutrición hasta 
la obesidad, en contextos agrarios y postindustriales, y a lo largo de 
la vida desde recién nacidos hasta la tercera edad. Una variedad de 
enfermedades contagiosas y no contagiosas producen complicaciones 
renales y muchas personas que padecen una insuficiencia renal no 
tienen acceso a la atención. Las causas, las consecuencias y los costes 
de las insuficiencias renales tienen implicaciones para la política de salud 
pública en todos los países. Los riesgos de la insuficiencia renal también 
están influenciados por la raza, el sexo, la ubicación y el estilo de vida.  
El aumento de las disparidades económicas y de salud, la migración, 
la transición demográfica, las condiciones de trabajo inseguras y las 
amenazas ambientales, los desastres naturales y la contaminación 
pueden frustrar los intentos de reducir la morbilidad y la mortalidad 
por insuficiencia renal. Se necesita un enfoque multisectorial para 
abordar la carga mundial de la insuficiencia renal. Los Objetivos de 
Desarrollo Sostenible (ODS) hacen hincapié en la importancia de un 
enfoque multisectorial de la salud. Planificamos las acciones para 
alcanzar todos los ODS con el potencial de mejorar la comprensión, 
la medición, la prevención y el tratamiento de la insuficiencia renal en 
todos los grupos de edad. Estas acciones también pueden fomentar 
innovaciones en el tratamiento y reducir la carga de dicha enfermedad 
en las generaciones futuras.
References
1. Resolution A/RES/70/1. Transforming our world: the 2030 agenda 
for sustainable development. In: Seventieth United Nations General 
Assembly, New York, 25 September 2015. New York: United Nations; 2015. 
Available from: http://www.un.org/ga/search/view_doc.asp?symbol=A/
RES/70/1&Lang=E [cited 2018 Mar 2].
2. Global action plan for the prevention and control of noncommunicable 
diseases 2013-2020. Geneva, Switzerland: World Health Organization; 
2013. Available from: http://apps.who.int/iris/bitstream/
handle/10665/94384/9789241506236_eng.pdf;jsessionid=9751C4DBBB8E
9450F3286CED0690CD21?sequence=1 [cited 2017 Apr 20].
3. 2008-2013 action plan for the global strategy for the prevention 
and control of noncommunicable diseases. Geneva: World Health 
Organization; 2009. Available from: http://apps.who.int/iris/bitstream/
handle/10665/44009/9789241597418_eng.pdf?sequence=1 [cited 2017 
Apr 20].
4. Pearce N, Ebrahim S, McKee M, Lamptey P, Barreto ML, Matheson D, et 
al. Global prevention and control of NCDs: limitations of the standard 
approach. J Public Health Policy. 2015 Nov;36(4):408–25. doi: http://dx.doi.
org/10.1057/jphp.2015.29 PMID: 26377446
5. Levin A, Tonelli M, Bonventre J, Coresh J, Donner JA, Fogo AB, et al.; ISN 
Global Kidney Health Summit participants. Global kidney health 2017 and 
beyond: a roadmap for closing gaps in care, research, and policy. Lancet. 
2017 Oct 21;390(10105):1888–917. doi: http://dx.doi.org/10.1016/S0140-
6736(17)30788-2 PMID: 28434650
6. Kassebaum NJ, Arora M, Barber RM, Bhutta ZA, Brown J, Carter A, et al.; 
GBD 2015 DALYs and HALE Collaborators. Global, regional, and national 
disability-adjusted life-years (DALYs) for 315 diseases and injuries and 
healthy life expectancy (HALE), 1990-2015: a systematic analysis for the 
Global Burden of Disease Study 2015. Lancet. 2016 10 8;388(10053):1603–
58. doi: http://dx.doi.org/10.1016/S0140-6736(16)31460-X PMID: 27733283
Bull World Health Organ 2018;96:414–422C| doi: http://dx.doi.org/10.2471/BLT.17.206441 421
Policy & practice
Reducing the burden of kidney disease Valerie A Luyckx et al.
7. Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al.; GBD 
2015 Mortality and Causes of Death Collaborators. Global, regional, and 
national life expectancy, all-cause mortality, and cause-specific mortality for 
249 causes of death, 1980-2015: a systematic analysis for the Global Burden 
of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1459–544. doi: http://
dx.doi.org/10.1016/S0140-6736(16)31012-1 PMID: 27733281
8. Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, et al. Worldwide 
access to treatment for end-stage kidney disease: a systematic review. 
Lancet. 2015 May 16;385(9981):1975–82. doi: http://dx.doi.org/10.1016/
S0140-6736(14)61601-9 PMID: 25777665
9. Mehta RL, Cerdá J, Burdmann EA, Tonelli M, García-García G, Jha V, et al. 
International Society of Nephrology’s 0by25 initiative for acute kidney injury 
(zero preventable deaths by 2025): a human rights case for nephrology. 
Lancet. 2015 Jun 27;385(9987):2616–43. doi: http://dx.doi.org/10.1016/
S0140-6736(15)60126-X PMID: 25777661
10. Noncommunicable diseases. Fact sheet [internet]. Geneva: World Health 
Organization; 2017. Available from: http://www.who.int/mediacentre/
factsheets/fs355/en/ [cited 2018 Mar 20].
11. Global status report on noncommunicable diseases 2014. Geneva: World 
Health Organization; 2014. Available from: http://apps.who.int/iris/
bitstream/handle/10665/148114/9789241564854_eng.pdf;jsessionid=19E4
FF995306BDD189D98617243563FD?sequence=1 [cited 2017 April 20].
12. Murray CJ, Barber RM, Foreman KJ, Abbasoglu Ozgoren A, Abd-Allah 
F, Abera SF, et al.; GBD 2013 DALYs and HALE Collaborators. Global, 
regional, and national disability-adjusted life years (DALYs) for 306 
diseases and injuries and healthy life expectancy (HALE) for 188 countries, 
1990-2013: quantifying the epidemiological transition. Lancet. 2015 
Nov 28;386(10009):2145–91. doi: http://dx.doi.org/10.1016/S0140-
6736(15)61340-X PMID: 26321261
13. Naghavi M, Abajobir AA, Abbafati C, Abbas KM, Abd-Allah F, Abera SF, 
et al.; GBD 2016 Causes of Death Collaborators. Global, regional, and 
national age-sex specific mortality for 264 causes of death, 1980-2016: a 
systematic analysis for the Global Burden of Disease Study 2016. Lancet. 
2017 Sep 16;390(10100):1151–210. doi: http://dx.doi.org/10.1016/S0140-
6736(17)32152-9 PMID: 28919116
14. Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic 
kidney disease to the global burden of major noncommunicable diseases. 
Kidney Int. 2011 Dec;80(12):1258–70. doi: http://dx.doi.org/10.1038/
ki.2011.368 PMID: 21993585
15. Chapter 9: healthcare expenditures for persons with ESRD [internet]. Ann 
Arbor: United States Renal Data System; 2017. Available from: https://www.
usrds.org/2017/view/v2_09.aspx [cited 2018 Mar 22].
16. Tonelli M, Muntner P, Lloyd A, Manns BJ, Klarenbach S, Pannu N, et al.; 
Alberta Kidney Disease Network. Risk of coronary events in people with 
chronic kidney disease compared with those with diabetes: a population-
level cohort study. Lancet. 2012 Sep 1;380(9844):807–14. doi: http://dx.doi.
org/10.1016/S0140-6736(12)60572-8 PMID: 22717317
17. Luyckx VA, Tuttle KR, Garcia Garcia G, Benghanem Gharbi M, Heerspink 
HJ, Johnson DW, et al. Reducing major risk factors for chronic kidney 
disease. Kidney Int Suppl. 2017;7(2):71–87. doi: http://dx.doi.org/10.1016/j.
kisu.2017.07.003
18. Tackling NCDs. ‘Best buys’ and other recommended interventions for 
the prevention and control of noncommunicable diseases. Geneva: 
World Health Organization; 2017. Available from: http://apps.who.
int/iris/bitstream/handle/10665/259232/WHO-NMH-NVI-17.9-eng.
pdf?sequence=1 [cited 2018 Feb 27].
19. Health in all policies: Helsinki statement. Framework for country action. 
Geneva: World Health Organization; 2014. Available from: http://apps.who.
int/iris/bitstream/10665/112636/1/9789241506908_eng.pdf?ua=1 [cited 
2016 Aug 31].
20. Norton JM, Moxey-Mims MM, Eggers PW, Narva AS, Star RA, Kimmel PL, et 
al. Social determinants of racial disparities in CKD. J Am Soc Nephrol. 2016 
Sep;27(9):2576–95. PMID: 27178804
21. Kishore SP, Vedanthan R, Fuster V. Promoting global cardiovascular health 
ensuring access to essential cardiovascular medicines in low- and middle-
income countries. J Am Coll Cardiol. 2011 May 17;57(20):1980–7. doi: http://
dx.doi.org/10.1016/j.jacc.2010.12.029 PMID: 21565635
22. Olowu WA, Niang A, Osafo C, Ashuntantang G, Arogundade FA, Porter J, et 
al. Outcomes of acute kidney injury in children and adults in sub-Saharan 
Africa: a systematic review. Lancet Glob Health. 2016 Apr;4(4):e242–50. doi: 
http://dx.doi.org/10.1016/S2214-109X(15)00322-8 PMID: 27013312
23. Jha V. Current status of end-stage renal disease care in India and Pakistan. 
Kidney Int Suppl. 2013;3(2):157–60. doi: http://dx.doi.org/10.1038/
kisup.2013.3
24. Moosa MR, Maree JD, Chirehwa MT, Benatar SR. Use of the ‘Accountability 
for reasonableness’ approach to improve fairness in accessing dialysis in a 
middle-income country. PLoS One. 2016 10 4;11(10):e0164201. doi: http://
dx.doi.org/10.1371/journal.pone.0164201 PMID: 27701466
25. McIntyre D, McKee M, Balabanova D, Atim C, Reddy KS, Patcharanarumol 
W; 250 signatories, a full list of signatories is available in the appendix. 
Open letter on the SDGs: a robust measure for universal health coverage 
is essential. Lancet. 2016 12 10;388(10062):2871–2. doi: http://dx.doi.
org/10.1016/S0140-6736(16)32189-4 PMID: 27863812
26. Low Birth Weight and Nephron Number Working Group. The impact of 
kidney development on the life course: a consensus document for action. 
Nephron. 2017;136(1):3–49. doi: http://dx.doi.org/10.1159/000457967 
PMID: 28319949
27. Freudenberg N. Healthy-food procurement: using the public plate to reduce 
food insecurity and diet-related diseases. Lancet Diabetes Endocrinol. 2016 
05;4(5):383–4. doi: http://dx.doi.org/10.1016/S2213-8587(16)00078-4 PMID: 
27055950
28. Colchero MA, Rivera-Dommarco J, Popkin BM, Ng SW. In Mexico, Evidence 
of sustained consumer response two years after implementing a sugar-
sweetened beverage tax. Health Aff (Millwood). 2017 03 1;36(3):564–71. 
doi: http://dx.doi.org/10.1377/hlthaff.2016.1231 PMID: 28228484
29. Bello AK, Levin A, Tonelli M, Okpechi IG, Feehally J, Harris D, et al. ISN 
Global Kidney Health Atlas. Brussels: International Society of Nephrology; 
2017. Available from: https://www.theisn.org/images/ISN_Biennial_
Report_2011-2013/GKHAtlas_Linked_Compressed1.pdf [cited 2018 Mar 30].
30. Cobo G, Hecking M, Port FK, Exner I, Lindholm B, Stenvinkel P, et al. Sex and 
gender differences in chronic kidney disease: progression to end-stage 
renal disease and haemodialysis. Clin Sci (Lond). 2016 07 1;130(14):1147–
63. doi: http://dx.doi.org/10.1042/CS20160047 PMID: 27252402
31. Harnessing the power of data for girls. taking stock and looking ahead 
to 2030. New York: United Nations Children’s Fund; 2016. Available from: 
https://www.unicef.org/gender/files/Harnessing-the-Power-of-Data-for-
Girls-Brochure-2016-1-1.pdf [cited 2018 Mar 30].
32. Beydoun MA, Poggi-Burke A, Zonderman AB, Rostant OS, Evans MK, Crews 
DC. Perceived discrimination and longitudinal change in kidney function 
among urban adults. Psychosom Med. 2017 Sep;79(7):824–34. doi: http://
dx.doi.org/10.1097/PSY.0000000000000478 PMID: 28445210
33. Lack of sanitation for 2.4 billion people is undermining health 
improvements. Final MDG progress report on water and sanitation released 
[internet]. Geneva: World Health Organization; 2015. Available from: http://
www.who.int/mediacentre/news/releases/2015/jmp-report/en/ [cited 
2017 Jul 3].
34. Stanifer JW, Muiru A, Jafar TH, Patel UD. Chronic kidney disease in low- and 
middle-income countries. Nephrol Dial Transplant. 2016 06;31(6):868–74. 
doi: http://dx.doi.org/10.1093/ndt/gfv466 PMID: 27217391
35. Overbo A, Williams AR, Evans B, Hunter PR, Bartram J. On-plot drinking 
water supplies and health: a systematic review. Int J Hyg Environ Health. 
2016 07;219(4-5):317–30. doi: http://dx.doi.org/10.1016/j.ijheh.2016.04.008 
PMID: 27118130
36. Lunyera J, Mohottige D, Von Isenburg M, Jeuland M, Patel UD, Stanifer JW. 
CKD of uncertain etiology: a systematic review. Clin J Am Soc Nephrol. 2016 
Mar 7;11(3):379–85. doi: http://dx.doi.org/10.2215/CJN.07500715 PMID: 
26712810
37. Johnson RJ, Stenvinkel P, Jensen T, Lanaspa MA, Roncal C, Song Z, et al. 
Metabolic and kidney diseases in the setting of climate change, water 
shortage, and survival factors. J Am Soc Nephrol. 2016 Aug;27(8):2247–56. 
doi: http://dx.doi.org/10.1681/ASN.2015121314 PMID: 27283495
38. Vonesch N, D’Ovidio MC, Melis P, Remoli ME, Ciufolini MG, Tomao P. Climate 
change, vector-borne diseases and working population. Ann Ist Super 
Sanita. 2016 Jul-Sep;52(3):397–405. Epub20161005. PMID: 27698298
39. Agar JW. Green dialysis: the environmental challenges ahead. Semin Dial. 
2015 Mar-Apr;28(2):186–92. doi: http://dx.doi.org/10.1111/sdi.12324 PMID: 
25440109
40. Muralidharan A, White S. The need for kidney transplantation in low- and 
middle-income countries in 2012: an epidemiological perspective. 
Transplantation. 2015 Mar;99(3):476–81. doi: http://dx.doi.org/10.1097/
TP.0000000000000657 PMID: 25680089
41. Mills KT, Xu Y, Zhang W, Bundy JD, Chen CS, Kelly TN, et al. A systematic 
analysis of worldwide population-based data on the global burden of 
chronic kidney disease in 2010. Kidney Int. 2015 Nov;88(5):950–7. doi: 
http://dx.doi.org/10.1038/ki.2015.230 PMID: 26221752
42. Giles-Corti B, Vernez-Moudon A, Reis R, Turrell G, Dannenberg AL, Badland 
H, et al. City planning and population health: a global challenge. Lancet. 
2016 12 10;388(10062):2912–24. doi: http://dx.doi.org/10.1016/S0140-
6736(16)30066-6 PMID: 27671668
Bull World Health Organ 2018;96:414–422C| doi: http://dx.doi.org/10.2471/BLT.17.206441422
Policy & practice
Reducing the burden of kidney disease Valerie A Luyckx et al.
43. Kickbusch I, Allen L, Franz C. The commercial determinants of health. Lancet 
Glob Health. 2016 Dec;4(12):e895–6. doi: http://dx.doi.org/10.1016/S2214-
109X(16)30217-0 PMID: 27855860
44. Yusuf S, Attaran A, Bosch J, Joseph P, Lonn E, McCready T, et al.; Working 
Group on the Summit on Combination Therapy for CVD. Combination 
pharmacotherapy to prevent cardiovascular disease: present status 
and challenges. Eur Heart J. 2014 Feb;35(6):353–64. doi: http://dx.doi.
org/10.1093/eurheartj/eht407 PMID: 24288261
45. McPhee M, Arumainayagam N, Clark M, Burfitt N, DasGupta R. Renal injury 
management in an urban trauma centre and implications for urological 
training. Ann R Coll Surg Engl. 2015 Apr;97(3):194–7. doi: http://dx.doi.org/1
0.1308/003588414X14055925061117 PMID: 26263803
46. Sever MS, Vanholder R, Ashkenazi I, Becker G, Better O, Covic A, et al.; 
RDRTF of ISN Work Group on Recommendations for the Management of 
Crush Victims in Mass Disasters. Recommendation for the management of 
crush victims in mass disasters. Nephrol Dial Transplant. 2012 Apr;27 Suppl 
1:i1–67. doi: http://dx.doi.org/10.1093/ndt/gfs156 PMID: 22467763
47. Isreb M, Alyousef M, Obaid N, Abbara A, Sekkarie M. Effect of besiegement 
on non-communicable diseases: haemodialysis. Lancet. 2016 11 
12;388(10058):2350. doi: http://dx.doi.org/10.1016/S0140-6736(16)32129-8 
PMID: 27845091
48. Cervantes L, Fischer S, Berlinger N, Zabalaga M, Camacho C, Linas S, et al. 
The illness experience of undocumented immigrants with end-stage renal 
disease. JAMA Intern Med. 2017 Apr 1;177(4):529–35. doi: http://dx.doi.
org/10.1001/jamainternmed.2016.8865 PMID: 28166331
49. Stewart IJ, Sosnov JA, Howard JT, Orman JA, Fang R, Morrow BD, et al. 
Retrospective analysis of long-term outcomes after combat injury: a hidden 
cost of war. Circulation. 2015 Dec 1;132(22):2126–33. doi: http://dx.doi.
org/10.1161/CIRCULATIONAHA.115.016950 PMID: 26621637
50. Nowotny KM, Rogers RG, Boardman JD. Racial disparities in health 
conditions among prisoners compared with the general population. SSM 
Popul Health. 2017 Dec;3(3):487–96. doi: http://dx.doi.org/10.1016/j.
ssmph.2017.05.011 PMID: 28824953
51. A/72/662. Progress on the prevention and control of non-communicable 
diseases. Report of the Secretary-General. In: Seventy-second United 
Nations General Assembly, New York, 21 December 2015. New York: United 
Nations; 2015. Available from: https://ncdalliance.org/sites/default/files/
resource_files/UNSG%20Report%20on%20NCDs%20December%20
2017%20A.72.662%20SG%20report.pdf [cited 2018 Mar 2].
Bull World Health Organ 2018;96:414–422C| doi: http://dx.doi.org/10.2471/BLT.17.206441 422A
Policy & practice
Reducing the burden of kidney disease Valerie A Luyckx et al.
Table 2. Relevance of the targets of sustainable development goal 3 to kidney disease, 2015
Target Description Relevant kidney 
condition
Strategies or actions to reduce risk  
of kidney disease
Policies facilitating improved  
kidney health
3.1 By 2030, reduce global 
maternal mortality to 
less than 70 deaths per 
100 000 live births
Pregnancy-related 
AKI and pre-
eclampsia
• Improve access to antenatal care and 
institutional deliveries and the recognition 
of pregnancy complications, e.g. 
eclampsia, pre-eclampsia and peripartum 
haemorrhage
UHC 
Promotion of gender equity 
Public health promotion of healthy lifestyles 
through education and regulation of 
unhealthy food and tobacco consumption 
Promotion of the consumption of healthy 
food
• Identify, during antenatal care or at 
delivery, mothers at risk, for education 
and follow-up to reduce long-term risk of 
maternal CKD and cardiovascular disease 
associated with pre-eclampsia
3.2 By 2030, end preventable 
deaths of neonates and 
children under 5 years 
of age, with all countries 
aiming to reduce neonatal 
mortality to no more 
than 12 deaths per 1000 
live births and mortality 
among children under 
5 years of age to no more 
than 25 deaths per 1000 
live births
Perinatal AKI • Reduce prematurity UHC 
Education of health-care workers 
Enhancement of the capacity and 
infrastructure for detection and surveillance
• Avoid or reduce perinatal use of 
nephrotoxins, e.g. aminoglycoside 
antibiotics and non-steroidal anti-
inflammatory drugs
• Optimize neonatal nutrition
CKD and 
hypertension in 
later life
• Reduce prematurity and low birth weight, 
which are both risk factors for low nephron 
numbers
UHC to improve access to prevention and 
screening services 
Public health promotion of healthy lifestyles 
through education and regulation of 
unhealthy food and tobacco consumption 
Adoption and implementation of the FCTC
Diarrhoea-
associated and 
HUS-associated 
AKI, post-infectious 
glomerulonephritis
• Improve sanitation and access to 
vaccinations and medical care
Development of public health policy to 
improve disease surveillance and response to 
outbreaks
3.3 By 2030, end the 
epidemics of AIDS, 
malaria, neglected 
tropical diseases and 
tuberculosis, and combat 
hepatitis, waterborne 
diseases and other 
communicable diseases
HIV nephropathy • Provide equitable access to services for the 
prevention and treatment of HIV infection
UHC 
Enactment of protections for women victims 
of domestic violence and sexual assault 
Taking action, including legal, policy and 
regulatory reforms, to ensure full political 
enfranchisement for women 
Legislation for the protection of sex workers
Malaria-associated 
AKI, black water 
fever
• Prevent and provide early treatment of 
malaria and combat both availability 
of fake medication and emergence of 
resistance to antimalarials
Development of public health policy to 
improve disease surveillance and response to 
outbreaks 
Reforming of pharmaceutical supply chains 
and enhancement of regulations to combat 
fake medicines
CKD – a risk factor 
for tuberculosis
• Increase awareness of risk Development of public health policy to 
improve disease surveillance and the 
effectiveness of diagnosis and treatment 
Development of innovative interventions to 
improve labour conditions and conditions in 
prisons
• Adapt medication doses according to 
kidney dysfunction
Hepatitis-
associated 
glomerulonephritis 
and hepatorenal 
syndrome
• Improve access to vaccination and 
treatment for hepatitis B and C
Provision of public education and UHC 
Development of care models integrating 
traditional healers. Legislation on alcohol 
consumption to reduce high-risk drinking
• Reduce hepatitis-associated inflammation 
and immune-complex deposition
• Reduce kidney-disease-associated cirrhosis 
and liver failure
CKD from 
infections
• Prevent and treat Hantavirus, leptospirosis 
and scrub typhus
Development of public health policy to 
improve disease surveillance and the 
effectiveness of diagnosis and treatment
Urinary obstruction • Reduce schistosomiasis Development of public health policy to 
improve disease surveillance and response to 
outbreaks
• Diagnose and treat kidney tuberculosis 
adequately, to reduce long-term 
obstruction of urinary tract
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Target Description Relevant kidney 
condition
Strategies or actions to reduce risk  
of kidney disease
Policies facilitating improved  
kidney health
3.4 By 2030, reduce by one 
third premature mortality 
from noncommunicable 
diseases through 
prevention and treatment 
and promote mental 
health and well-being
CKD • Prevent and screen for CKD, improve access 
to early diagnosis and effective treatment 
for CKD, provide equitable access to 
treatment for kidney failure, i.e. dialysis and 
transplantation, and strengthen access to 
options for lifestyle improvement
UHC 
Enactment of protections for women victims 
of domestic violence and sexual assault 
Taking action, including legal, policy and 
regulatory reforms, to ensure full political 
enfranchisement for women 
Promotion of healthy lifestyles through 
education and regulation of unhealthy food 
consumption 
Adoption and implementation of FCTC 
Enhancement of capacity and infrastructure 
for detection and surveillance 
Development of care models integrating 
traditional healers. Enhancement of 
occupational safety standards 
Development of transparent policies 
governing access to expensive therapies such 
as dialysis and transplantation
• Reduction in CKD could reduce morbidity 
and mortality associated with some other 
diseases, e.g. cancer, diabetes and liver 
disease
Cardiovascular 
disease
• Reduce CKD, this should reduce the 
burdens posed by global hypertension and 
cardiovascular disease and the associated 
mortality
AKI • Prevent AKI through improved access 
to sanitation and vaccination, decrease 
reliance on toxic traditional remedies, 
improve access to early diagnosis and 
effective treatment for AKI and provide 
equitable access to dialysis
• Reduction in AKI could reduce morbidity 
and mortality associated with some other 
conditions, e.g. heart failure, liver disease, 
sepsis and surgery
3.5 Strengthen the 
prevention and treatment 
of substance abuse, 
including narcotic drug 
abuse and harmful use of 
alcohol
CKD and 
hypertension in 
later life
• Reduce low birth weight associated with 
alcohol use, smoking and substance abuse 
in pregnancy
UHC 
Enactment of protection for women victims 
of domestic violence and sexual assault 
Taking action, including legal, policy and 
regulatory policy reforms, to ensure full 
political enfranchisement for women 
Promotion of urban safety 
Legislation and regulation of alcohol 
consumption 
Adoption and implementation of FCTC 
Legislation for the protection of sex workers
• Alcohol use and smoking are risk factors 
for CKD progression
HIV and hepatitis-
associated kidney 
disease, infectious 
glomerulonephritis
• Reduce infections transmitted by 
intravenous drug use
Rhabdomyolysis • Prevent rhabdomyolysis by increasing 
awareness and providing treatment for 
drug withdrawal and delirium tremens
3.6 By 2020, halve the 
number of global deaths 
and injuries from road 
traffic accidents
AKI • Prevent trauma-related crush injury or 
blunt kidney trauma
Enforcement of existing traffic laws and 
reform of traffic laws to reduce road trauma 
Promotion of occupational safety 
Development and building of infrastructure 
and safe roads, with capacity to absorb urban 
growth
CKD • Prevent accident-related losses in 
employment, increases in poverty and 
reductions in access to health care
3.7 By 2030, ensure 
universal access to 
sexual and reproductive 
health-care services, 
including for family 
planning, information 
and education, and 
the integration of 
reproductive health into 
national strategies and 
programmes
Pregnancy-related 
AKI, CKD
• Empower women, increase spacing 
of pregnancies and reduce teenage 
pregnancies
Promotion of access to education for all and 
family planning, gender equity and UHC 
Strengthen legislation on access to safe 
abortion and the protection of sex workers• Reduce risk of low birth weight and 
preterm birth, as these can adversely affect 
kidney health of the child
3.8 Achieve UHC, including 
financial risk protection, 
access to quality essential 
health-care services and 
access to safe, effective, 
quality and affordable 
essential medicines and 
vaccines for all
AKI, CKD • Provide universal access to basic health 
care and services for the diagnosis, 
prevention and treatment of all kidney 
disease and its risk factors, e.g. diabetes 
and hypertension
Promotion of innovative financing, regulation 
of the pricing of medical products and UHC 
Monitoring of catastrophic health 
expenditure
(. . .continued)
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Target Description Relevant kidney 
condition
Strategies or actions to reduce risk  
of kidney disease
Policies facilitating improved  
kidney health
3.9 By 2030, substantially 
reduce the number of 
deaths and illnesses 
from hazardous 
chemicals and air, water 
and soil pollution and 
contamination
CKD of unknown 
origin, observed in 
Egypt, India and Sri 
Lanka, and Balkan 
nephropathy
• Reduce exposure to environmental toxins 
that may be associated with CKD, e.g. 
aristolochic acid and cadmium and others
Promotion of environmental protection and 
safety 
Promotion of sustainable agriculture and 
fishing 
Commitment to combat climate change
3.a Strengthen the 
implementation of WHO’s 
FCTC in all countries, as 
appropriate
CKD • Reduce tobacco smoking, a risk factor 
for cardiovascular disease and mortality, 
haematuria, low birth weight and 
proteinuria
Adoption and implementation of FCTC
3.b Support the research 
and development of 
vaccines and medicines 
for the communicable 
and noncommunicable 
diseases that primarily 
affect developing 
countries, provide access 
to affordable essential 
medicines and vaccines, 
in accordance with the 
Doha Declaration on the 
TRIPS Agreement and 
Public Health, which 
affirms the right of 
developing countries 
to use to the full, the 
provisions in the TRIPS 
Agreement regarding 
flexibilities to protect 
public health and, in 
particular, provide access 
to medicines for all
AKI • Provide and support the uptake of vaccines 
that can prevent diarrhoeal illness, sepsis 
and other infections that can cause AKI 
and can prevent low birth weight in 
pregnancy
Promotion of budget allocation for locally 
relevant research 
Strengthening and empowerment of local 
research ethics committees 
Utilization of TRIPS Agreement exemptions 
Enhancement of the regulation of generic 
medication 
Monitoring of medication supply and use 
Promotion of health technology assessments 
Development of transparent policies 
governing access to expensive therapies, e.g. 
dialysis and transplantation 
Development of innovative financing models 
to reduce costs of dialysis and transplantation 
Implementation and enforcement of the 
Istanbul Declaration against organ trafficking 
Development of legislation regarding brain 
death and organ donation 
Opt-out or presumed-consent policies for 
organ donation
• Support prompt access to the intravenous 
fluid and appropriate antibiotics that can 
prevent AKI and glomerulonephritisd
• Vaccination in pregnancy can reduce the 
risk of low birth weight
• Vaccination during pregnancy can reduce 
the incidence of low birth weight
CKD • Provide affordable and sustainable access 
to basic medications for CKD, diabetes and 
hypertension and so reduce burden of 
end-stage kidney disease
ESKD • Devise innovative ways to deliver cheaper 
dialysis worldwide
Transplantation • Promote safe and altruistic kidney 
donation by living donors. Improve supply 
from deceased donors where permissible. 
Stop organ trafficking
3.c Substantially increase 
health financing 
and the recruitment, 
development, training 
and retention of the 
health workforce in 
developing countries, 
especially in least 
developed countries and 
small island developing 
states
Kidney disease 
awareness and 
capacity to treat
• Improve awareness and capacity to 
diagnose, prevent and treat kidney disease
Development of innovative financing models 
to reduce costs of dialysis and transplantation 
Promotion of the education, licensing and 
registration of health-care workers and 
researchers 
Promotion of the fair remuneration of health-
care workers 
Legislation to define the scope of practice 
of community health workers and any 
associated task shifting
• Train and retain health-care workers with 
knowledge of kidney disease
3.d Strengthen the capacity 
of all countries, in 
particular developing 
countries, for early 
warning, risk reduction 
and management of 
national and global health 
risks
Crush syndrome • Improve disaster planning and responses 
to earthquakes and other major disasters
Promotion of international collaboration to 
respond to natural disasters 
Commitment to equality and peace 
Promotion of democracy 
Strengthening of intersectoral 
communication and collaboration
CKD • Promote peace
• Prevention of wars should reduce both the 
burden of kidney disease associated with 
low birth weight and malnutrition and the 
conflict-related disruption of care
AIDS: acquired immunodeficiency syndrome; AKI: acute kidney injury; CKD: chronic kidney disease; ESKD; end-stage kidney disease; FCTC: Framework Convention on 
Tobacco Control; HIV: human immunodeficiency virus; HUS: haemolytic uraemic syndrome; TRIPS: Trade-related Aspects of Intellectual Property Rights; UHC: universal 
health coverage; WHO: World Health Organization.
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